Abstract
Panic disorder (PD) is a severe and often disabling psychiatric condition whose neurobiology is not yet fully understood. Existing clinical and preclinical evidence suggests a critical role of orexin (ORX) in the pathophysiology of PD. Studies have demonstrated that systemic treatment with the type 1 orexinergic receptor antagonist (OX1R) attenuated behavioral and autonomic responses indu…